{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:28:43Z","timestamp":1782937723211,"version":"3.54.5"},"reference-count":22,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpm-2024-0024_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To compare neonatal morbidity in late preterm pregnancies with small-for-gestational-age fetuses, between those exposed and not exposed to antenatal corticosteroids (ACS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2024-0024_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study which included growth-restricted fetuses delivered at gestational week 34+0 to 36+6\u00a0weeks at a tertiary university-affiliated hospital, from\u00a0March 2016 to March 2022. The primary composite outcome included the need for oxygen therapy or ventilation, respiratory distress syndrome, transient tachypnea of the newborn, bronchopulmonary dysplasia, necrotizing enterocolitis, intraventricular hemorrhage grade III\/IV and neonatal mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2024-0024_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The primary composite outcome was comparable between those who did and did not receive ACS (26.1 vs. 20.8\u202f%, p=0.512). Neonatal morbidity rates did not differ significantly between the groups, except for hypoglycemia, which was more common among neonates from ACS-exposed mothers (37.0 vs. 19.5\u202f%, p=0.037). Multivariate analysis, adjusted for gestational diabetes and the mode of delivery showed no significant difference in the composite outcome between the groups (OR=2.03, 95\u202f% CI 0.79\u20135.20, p=0.142). Cesarean delivery was associated with a higher risk of the primary outcome (OR=2.13, 95\u202f% CI 1.17\u20133.85, p=0.013). After excluding those who did not receive the initial betamethasone dose within 2\u20137\u00a0days before delivery, the primary composite outcome remained similar between the groups. The primary composite outcome was similar among severely growth-restricted fetuses (&lt;5th percentile) exposed and not exposed to\u00a0ACS (29.2 vs. 22.0\u202f%, p=0.560).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2024-0024_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among preterm pregnancies complicated by small-for-gestational-age fetuses, ACS did not lower the rate of neonatal morbidity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpm-2024-0024","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T11:41:13Z","timestamp":1728992473000},"page":"88-93","source":"Crossref","is-referenced-by-count":1,"title":["Antenatal corticosteroids for late small-for-gestational-age fetuses"],"prefix":"10.1515","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5270-8436","authenticated-orcid":false,"given":"Inshirah","family":"Sgayer","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology , 61255 Galilee Medical Center , Nahariya , Israel"},{"name":"Azrieli Faculty of Medicine , Bar Ilan University , Safed , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sondos","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , 61255 Galilee Medical Center , Nahariya , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Sarhan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , 61255 Galilee Medical Center , Nahariya , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Ashkar","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , 61255 Galilee Medical Center , Nahariya , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Lowenstein","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , 61255 Galilee Medical Center , Nahariya , Israel"},{"name":"Azrieli Faculty of Medicine , Bar Ilan University , Safed , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya Frank","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , 61255 Galilee Medical Center , Nahariya , Israel"},{"name":"Azrieli Faculty of Medicine , Bar Ilan University , Safed , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"2026031011010941298_j_jpm-2024-0024_ref_001","doi-asserted-by":"crossref","unstructured":"McGoldrick, E, Stewart, F, Parker, R, Dalziel, SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2020;12. https:\/\/doi.org\/10.1002\/14651858.CD004454.pub4.","DOI":"10.1002\/14651858.CD004454.pub4"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_002","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u00a0\u2013 Obstetrics and the Society for Maternal-Fetal Medicine. ACOG practice bulletin No. 204: fetal growth restriction. Obstet Gynecol 2019;133. https:\/\/doi.org\/10.1097\/AOG.0000000000003070.","DOI":"10.1097\/AOG.0000000000003070"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_003","doi-asserted-by":"crossref","unstructured":"Gyamfi-Bannerman, C, Thom, EA, Blackwell, SC, Tita, ATN, Rouse, DJ, McKenna, DS, et al.. Antenatal betamethasone for women at risk for late preterm delivery [published correction appears in N Engl J Med. 2023 May 4;388(18):1728]. N Engl J Med 2016;374:1311\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1516783.","DOI":"10.1056\/NEJMoa1516783"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_004","doi-asserted-by":"crossref","unstructured":"Vidaeff, AC, Belfort, MA, Kemp, MW, Saade, GR, Caughey, AB, Wapner, RJ, et al.. Updating the balance between benefits and harms of antenatal corticosteroids. Am J Obstet Gynecol 2023;228:129\u201332. https:\/\/doi.org\/10.1016\/j.ajog.2022.10.002.","DOI":"10.1016\/j.ajog.2022.10.002"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_005","doi-asserted-by":"crossref","unstructured":"Gordijn, SJ, Beune, IM, Thilaganathan, B, Papageorghiou, A, Baschat, AA, Baker, PN, et al.. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol 2016;48:333\u20139. https:\/\/doi.org\/10.1002\/uog.15884.","DOI":"10.1002\/uog.15884"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_006","doi-asserted-by":"crossref","unstructured":"Blankenship, SA, Brown, KE, Simon, LE, Stout, MJ, Tuuli, MG. Antenatal corticosteroids in preterm small-for-gestational age infants: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020;2:100215. https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100215.","DOI":"10.1016\/j.ajogmf.2020.100215"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_007","doi-asserted-by":"crossref","unstructured":"Huang, WL, Beazley, LD, Quinlivan, JA, Evans, SF, Newnham, JP, Dunlop, SA. Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol. 1999;94:213\u201318. https:\/\/doi.org\/10.1016\/s0029-7844(99)00265-3.","DOI":"10.1097\/00006250-199908000-00011"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_008","doi-asserted-by":"crossref","unstructured":"Miller, SL, Chai, M, Loose, J, Castillo-Mel\u00e9ndez, M, Walker, DV, Genkin, G, et al.. The effects of maternal betamethasone administration on the intrauterine growth-restricted fetus. Endocrinology 2007;148:1288\u201395. https:\/\/doi.org\/10.1210\/en.2006-1058.","DOI":"10.1210\/en.2006-1058"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_009","doi-asserted-by":"crossref","unstructured":"Liauw, J, Foggin, H, Socha, P, Crane, J, Joseph, KS, Burrows, J, et al.. Technical update No. 439: antenatal corticosteroids at late preterm gestation. J Obstet Gynaecol Can. 2023;45:445\u201357.e2. Erratum in: J Obstet Gynaecol Can. 2023;45(12):102270. https:\/\/doi.org\/10.1016\/j.jogc.2022.12.006. Epub 2022 Dec 23.","DOI":"10.1016\/j.jogc.2023.102270"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_010","doi-asserted-by":"crossref","unstructured":"Bitar, G, Merrill, SJ, Sciscione, AC, Hoffman, MK. Antenatal corticosteroids in the late preterm period for growth-restricted pregnancies. Am J Obstet Gynecol MFM 2020;2:100153. https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100153.","DOI":"10.1016\/j.ajogmf.2020.100153"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_011","doi-asserted-by":"crossref","unstructured":"Familiari, A, Napolitano, R, Visser, GHA, Lees, C, Wolf, H, Prefumo, F, et al.. Antenatal corticosteroids and perinatal outcome in late fetal growth restriction: analysis of prospective cohort. Ultrasound Obstet Gynecol 2023;61:191\u20137. https:\/\/doi.org\/10.1002\/uog.26127.","DOI":"10.1002\/uog.26127"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_012","unstructured":"Dollberg, S, Haklai, Z, Mimouni, FB, Gorfein, I, Gordon, ES. Birth weight standards in the live-born population in Israel. Isr Med Assoc J 2005;7:311\u201314."},{"key":"2026031011010941298_j_jpm-2024-0024_ref_013","doi-asserted-by":"crossref","unstructured":"Spinillo, A, Ometto, A, Bottino, R, Piazzi, G, Iasci, A, Rondini, G. Antenatal risk factors for germinal matrix hemorrhage and intraventricular hemorrhage in preterm infants. Eur J Obstet Gynecol Reprod Biol 1995;60:13\u201319. https:\/\/doi.org\/10.1016\/0028-2243(95)02052-7.","DOI":"10.1016\/0028-2243(95)02052-7"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_014","doi-asserted-by":"crossref","unstructured":"Bernstein, IM, Horbar, JD, Badger, GJ, Ohlsson, A, Golan, A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 2000;182:198\u2013206. https:\/\/doi.org\/10.1016\/s0002-9378(00)70513-8.","DOI":"10.1016\/S0002-9378(00)70513-8"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_015","doi-asserted-by":"crossref","unstructured":"Committee on Obstetric Practice. Committee opinion No. 713: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017;130. https:\/\/doi.org\/10.1097\/AOG.0000000000002237.","DOI":"10.1097\/AOG.0000000000002237"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_016","doi-asserted-by":"crossref","unstructured":"Society for Maternal-Fetal Medicine (SMFM), Reddy, UM, Deshmukh, U, Dude, A, Harper, L, Osmundson, SS. Society for Maternal-Fetal Medicine Consult Series #58: use of antenatal corticosteroids for individuals at risk for late preterm delivery: replaces SMFM Statement #4, implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016. Am J Obstet Gynecol 2021;225. https:\/\/doi.org\/10.1016\/j.ajog.2021.07.023.","DOI":"10.1016\/j.ajog.2021.07.023"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_017","doi-asserted-by":"crossref","unstructured":"Norman, J, Shennan, A, Jacobsson, B, Stock, SJ, on behalf of the FIGO Working Group for Preterm Birth. FIGO good practice recommendations on the use of prenatal corticosteroids to improve outcomes and minimize harm in babies born preterm. Int J Gynecol Obstet 2021;155:26\u201330. https:\/\/doi.org\/10.1002\/ijgo.13836.","DOI":"10.1002\/ijgo.13836"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_018","doi-asserted-by":"crossref","unstructured":"Dagklis, T, Sen, C, Tsakiridis, I, Villala\u00edn, C, Allegaert, K, Wellmann, S, et al.. The use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine foundation. J Perinat Med 2022;50:375\u201385. https:\/\/doi.org\/10.1515\/jpm-2022-0066.","DOI":"10.1515\/jpm-2022-0066"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_019","doi-asserted-by":"crossref","unstructured":"Ninan, K, Liyanage, SK, Murphy, KE, Asztalos, EV, McDonald, SD. Evaluation of long-term outcomes associated with preterm exposure to antenatal corticosteroids: a systematic review and meta-analysis. JAMA Pediatr 2022;176. https:\/\/doi.org\/10.1001\/jamapediatrics.2022.0483.","DOI":"10.1001\/jamapediatrics.2022.0483"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_020","doi-asserted-by":"crossref","unstructured":"Torrance, HL, Derks, JB, Scherjon, SA, Wijnberger, LD, Visser, GH. Is antenatal steroid treatment effective in preterm IUGR fetuses? Acta Obstet Gynecol Scand 2009;88:1068\u201373. https:\/\/doi.org\/10.1080\/00016340903176784.","DOI":"10.1080\/00016340903176784"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_021","doi-asserted-by":"crossref","unstructured":"Hodyl, NA, Crawford, TM, McKerracher, L, Lawrence, A, Pitcher, JB, Stark, MJ. Antenatal steroid exposure in the late preterm period is associated with reduced cord blood neurotrophin-3. Early Hum Dev 2016;101:57\u201362. https:\/\/doi.org\/10.1016\/j.earlhumdev.2016.03.016.","DOI":"10.1016\/j.earlhumdev.2016.03.016"},{"key":"2026031011010941298_j_jpm-2024-0024_ref_022","doi-asserted-by":"crossref","unstructured":"Callec, R, Lamy, C, Perdriolle-Galet, E, Patte, C, Heude, B, Morel, O, et al.. Impact on obstetric outcome of third-trimester screening for small-for-gestational-age fetuses. Ultrasound Obstet Gynecol 2015;46:216\u201320. https:\/\/doi.org\/10.1002\/uog.14755.","DOI":"10.1002\/uog.14755"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0024\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0024\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:01:28Z","timestamp":1773140488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2024-0024\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,10,16]]},"published-print":{"date-parts":[[2025,1,29]]}},"alternative-id":["10.1515\/jpm-2024-0024"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2024-0024","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]}}}